Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-80

SponsorFederico II University

About this trial

Evaluation of adherence, persistence and efficacy of treatment with alirocumab 300 mg in a real-life Italian population.

None

Age < 18 years o > 80 years;

Patients who refuse to participate and to sign informed consent.

1,500 Participants

are divided into 1 treatment group

Federico II University

Lead sponsor